Jalava Jari, Vaara Martti, Huovinen Pentti
Department of Human Microbial Ecology and Inflammation, National Public Health Institute, Kiinamyllynkatu 13, 20520 Turku, Finland.
Ann Clin Microbiol Antimicrob. 2004 May 6;3:5. doi: 10.1186/1476-0711-3-5.
In streptococci, three macrolide resistance determinants (erm(B), erm(TR) and mef(A)) have been found. In addition, certain mutations at the ribosomal 23S RNA can cause resistance to macrolides. Mutation at the position 2058 of the 23S rRNA of the Streptococcus pyogenes as a cause of macrolide resistance has not been described before.
Antibiotic resistance determinations for the clinical S. pyogenes strain ni4277 were done using the agar dilution technique. Macrolide resistance mechanisms were studied by PCR and sequencing. All six rRNA operons were amplified using operon-specific PCR. The PCR products were partially sequenced in order to resolve the sequences of different 23S rRNA genes.
One clinical isolate of S. pyogenes carrying an adenine to guanine mutation at the position 2058 of the 23S rRNA in five of the six possible rRNA genes but having no other known macrolide resistance determinants is described. The strain was highly resistant to macrolides and azalides, having erythromycin and azithromycin MICs > 256 microgram/ml. It was resistant to lincosamides (clindamycin MIC 16 microgram/ml) and also MIC values for ketolides were clearly elevated. The MIC for telithromycin was 16 microgram/ml.
In this clinical S. pyogenes strain, a mutation at the position 2058 was detected. No other macrolide resistance-causing determinants were detected. This mutation is known to cause macrolide resistance in other bacteria. We can conclude that this mutation was the most probable cause of macrolide, lincosamide and ketolide resistance in this strain.
在链球菌中,已发现三种大环内酯类抗性决定因素(erm(B)、erm(TR) 和 mef(A))。此外,核糖体 23S RNA 上的某些突变可导致对大环内酯类药物产生抗性。化脓性链球菌 23S rRNA 第 2058 位的突变作为大环内酯类抗性的原因此前尚未见报道。
采用琼脂稀释技术对临床分离的化脓性链球菌菌株 ni4277 进行抗生素抗性测定。通过聚合酶链反应(PCR)和测序研究大环内酯类抗性机制。使用操纵子特异性 PCR 扩增所有六个 rRNA 操纵子。对 PCR 产物进行部分测序以解析不同 23S rRNA 基因的序列。
描述了一株化脓性链球菌临床分离株,其六个可能的 rRNA 基因中有五个在 23S rRNA 的第 2058 位存在腺嘌呤到鸟嘌呤的突变,但没有其他已知的大环内酯类抗性决定因素。该菌株对大环内酯类和氮杂内酯类高度耐药,红霉素和阿奇霉素的最低抑菌浓度(MIC)>256 微克/毫升。它对林可酰胺类(克林霉素 MIC 为 16 微克/毫升)耐药,并且酮内酯类的 MIC 值也明显升高。替利霉素的 MIC 为 16 微克/毫升。
在该化脓性链球菌临床菌株中,检测到第 2058 位的突变。未检测到其他导致大环内酯类抗性的决定因素。已知该突变在其他细菌中可导致大环内酯类抗性。我们可以得出结论,该突变是该菌株中大环内酯类、林可酰胺类和酮内酯类抗性的最可能原因。